On September 2, 2020 Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, reported that members of its management team will participate in three upcoming virtual investor conferences. The details for the three conferences are (Press release, Syndax, SEP 2, 2020, View Source [SID1234564267]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020. Panel at 11:40 a.m. ET.
Baird 2020 Virtual Global Healthcare Conference on Thursday, September 10, 2020. Fireside chat at 4:20 p.m. ET.
Morgan Stanley 18th Annual Global Virtual Healthcare Conference on Monday, September 14, 2020. Fireside chat at 2:15 p.m. ET.
A live webcast of the events can be accessed from the Investor section of the Company’s website at www.syndax.com, where a replay of the event will also be available for a limited time.